Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert M Califf

Showing results (361-370 of 770) with videos related to

Pageof 77
Sort By:
Journal of the American College of Cardiology|June 27, 2002
Early angioplasty in acute coronary syndromes without persistent ST-segment elevation improves outcome but increases the need for six-month repeat revascularization: an analysis of the PURSUIT Trial. Platelet glycoprotein IIB/IIIA in Unstable angina: Receptor Suppression Using Integrilin TherapyEelko Ronner, Eric Boersma, Gert-Jan Laarman, et al.
Circulation|December 8, 2004
Lessons learned from a clinical trialPaul W Armstrong, L Kristin Newby, Christopher B Granger, et al.
American Heart Journal|June 23, 2007
Relationship between depressive symptoms and long-term mortality in patients with heart failureWei Jiang, Maragatha Kuchibhatla, Greg L Clary, et al.
Circulation|January 13, 2006
Long-term adherence to evidence-based secondary prevention therapies in coronary artery diseaseL Kristin Newby, Nancy M Allen LaPointe, Anita Y Chen, et al.
Journal of Cardiac Failure|December 19, 2006
Racial differences in the characteristics of patients admitted for acute decompensated heart failure and their relation to outcomes: results from the OPTIME-CHF trialMelvin R Echols, G Michael Felker, Kevin L Thomas, et al.
Journal of the American College of Cardiology|June 11, 2013
Effects of nesiritide and predictors of urine output in acute decompensated heart failure: results from ASCEND-HF (acute study of clinical effectiveness of nesiritide and decompensated heart failure)Stephen S Gottlieb, Amanda Stebbins, Adriaan A Voors, et al.
American Heart Journal|March 5, 2013
Dynamic modeling of 90-day mortality in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary interventionCynthia M Westerhout, Karen S Pieper, Stefan K James, et al.
American Journal of Nephrology|June 6, 2013
Cardiovascular toxicity of epoetin-alfa in patients with chronic kidney diseasePeter A McCullough, Huiman X Barnhart, Jula K Inrig, et al.
Hypertension (Dallas, Tex. : 1979)|March 12, 2008
Pediatric antihypertensive trial failures: analysis of end points and dose rangeDaniel K Benjamin, P Brian Smith, Pravin Jadhav, et al.
The American Journal of Medicine|July 11, 2002
Multi-year follow-up of abciximab therapy in three randomized, placebo-controlled trials of percutaneous coronary revascularizationEric J Topol, A Michael Lincoff, Dean J Kereiakes, et al.
Pageof 77

Showing results (361-370 of 770) with videos related to

Sort By:
Pageof 77
Journal of the American College of Cardiology|June 27, 2002
Early angioplasty in acute coronary syndromes without persistent ST-segment elevation improves outcome but increases the need for six-month repeat revascularization: an analysis of the PURSUIT Trial. Platelet glycoprotein IIB/IIIA in Unstable angina: Receptor Suppression Using Integrilin TherapyEelko Ronner, Eric Boersma, Gert-Jan Laarman, et al.
Circulation|December 8, 2004
Lessons learned from a clinical trialPaul W Armstrong, L Kristin Newby, Christopher B Granger, et al.
American Heart Journal|June 23, 2007
Relationship between depressive symptoms and long-term mortality in patients with heart failureWei Jiang, Maragatha Kuchibhatla, Greg L Clary, et al.
Circulation|January 13, 2006
Long-term adherence to evidence-based secondary prevention therapies in coronary artery diseaseL Kristin Newby, Nancy M Allen LaPointe, Anita Y Chen, et al.
Journal of Cardiac Failure|December 19, 2006
Racial differences in the characteristics of patients admitted for acute decompensated heart failure and their relation to outcomes: results from the OPTIME-CHF trialMelvin R Echols, G Michael Felker, Kevin L Thomas, et al.
Journal of the American College of Cardiology|June 11, 2013
Effects of nesiritide and predictors of urine output in acute decompensated heart failure: results from ASCEND-HF (acute study of clinical effectiveness of nesiritide and decompensated heart failure)Stephen S Gottlieb, Amanda Stebbins, Adriaan A Voors, et al.
American Heart Journal|March 5, 2013
Dynamic modeling of 90-day mortality in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary interventionCynthia M Westerhout, Karen S Pieper, Stefan K James, et al.
American Journal of Nephrology|June 6, 2013
Cardiovascular toxicity of epoetin-alfa in patients with chronic kidney diseasePeter A McCullough, Huiman X Barnhart, Jula K Inrig, et al.
Hypertension (Dallas, Tex. : 1979)|March 12, 2008
Pediatric antihypertensive trial failures: analysis of end points and dose rangeDaniel K Benjamin, P Brian Smith, Pravin Jadhav, et al.
The American Journal of Medicine|July 11, 2002
Multi-year follow-up of abciximab therapy in three randomized, placebo-controlled trials of percutaneous coronary revascularizationEric J Topol, A Michael Lincoff, Dean J Kereiakes, et al.
Pageof 77